 |
|
In a year in which the United States has brought and prosecuted a series of high-profile criminal cases under the Economic Espionage Act (“EEA”), another one was recently added to the roll call in the Southern District of Indiana, this time against two former high-level scientists with pharmaceutical giant, Eli Lilly.
This case is important for two reasons. First, it continues a year-long upswing in cases in which the United States brought charges under the EEA. According to Matthew Levine’s article, “With Expansion of Economic Espionage Act, Will More Prosecutions Follow?”, through November 2012, the United States brought 12 prosecutions under the Act. Since the enactment of the Theft of Trade Secrets Clarification Act of 2012 and only through July 2013, the United States brought 15 cases. (Transactional Records Access Clearinghouse, TRAC Reports, Prosecutions and Convictions for 2013, Lead Charges of 18 U.S.C. 1831 & 1832.)
|
|
|
|
